{"id":1082073,"title":"DSEN Abstract: Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-20","captureTimestamp":"2026-03-20T21:35:17.599000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53927.html?wbdisable=true","snippet":"DSEN Abstract Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Our findings suggest that many patients received valsartan products with nitrosamine…","rawSnapshotUrl":"/api/snapshots/raw/1082073","browseUrl":"https://replay.healtharchive.ca/job-8/20260320213517/https://cihr-irsc.gc.ca/e/53927.html?wbdisable=true#ha_snapshot=1082073","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}